“Association Between Early Clinical Responses and Long-Term Outcomes With Ruxolitinib Cream Treatment in Mild to Moderate Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 2, Mar. 2024, p. s373, https://doi.org/10.25251/skin.8.supp.373.